Ketamine Clinic Market Report 2026

The ketamine clinic market size has grown strongly in recent years. It will grow from $1.32 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of treatment-resistant depression, increased awareness of ketamine therapy benefits, expansion of outpatient mental health services, availability of trained medical professionals, growing patient demand for alternative therapies.

The ketamine clinic market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing regulatory clarity for ketamine treatments, rising investments in mental health infrastructure, expansion of digital mental health platforms, growing clinical research on psychedelic-assisted therapy, increasing acceptance of novel psychiatric treatments. Major trends in the forecast period include increasing expansion of specialized ketamine treatment centers, rising adoption of ketamine for mental health disorders, growing integration of psychotherapy with pharmacological treatment, expansion of telehealth-enabled ketamine services, enhanced focus on clinical safety and monitoring.

The rising prevalence of mental health conditions is expected to drive the growth of the ketamine clinic market in the coming years. Mental health conditions involve disruptions in a person’s emotions, thinking, or behavior, which can affect daily functioning and social interactions. A key factor contributing to the increase in mental health conditions is the growing sense of social isolation, where reduced human interaction and support lead to heightened emotional and psychological stress. Ketamine clinics help address mental health conditions by providing fast-acting treatments that alleviate symptoms of anxiety and depression, preventing these issues from progressing into more severe mental health disorders. For example, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, 11% of children aged 3 to 17 were reported to have anxiety at the time of diagnosis between 2022 and 2023, with rates of 9% for boys and 12% for girls, while 8% had a diagnosed behavioral disorder, affecting 10% of boys and 5% of girls. Consequently, the increasing prevalence of mental health conditions is fueling the growth of the ketamine clinic market.

Leading companies in the ketamine clinic market are concentrating on developing advanced solutions, such as evidence-based therapies, which follow structured and tested methods to ensure consistent outcomes. Evidence-based therapies are treatment approaches validated through systematic research and clinical studies for addressing specific psychological or behavioral issues. For instance, in June 2025, Rooted Rhythm Therapy, a US-based mental health therapy provider, together with Noma Therapy, a US-based ketamine-assisted psychotherapy provider, launched an insurance-covered ketamine therapy program that combines expert somatic care with professional psychotherapy support. This program is specifically designed for parents experiencing depression, anxiety, burnout, or trauma. It integrates ketamine-assisted therapy from Noma, guided by clinical expertise, with Rooted Rhythm’s parent-focused approach to emotional support and education. The services include insurance-covered ketamine treatment, professional guidance for dosing and medication management, and individual and group therapy sessions centered on emotional regulation, somatic practices, and schedules that accommodate family life.

In February 2024, Ketamine Wellness Clinic of Orange County, a US-based ketamine therapy provider, acquired Mind Space Ketamine Infusion Clinic for an undisclosed amount. Following the acquisition, the combined clinics will offer a wider range of treatment options for mood- and pain-related conditions. This collaboration is also expected to enhance patient care services throughout Laguna Beach and the greater Orange County region by implementing more advanced ketamine therapy methods. Mind Space Ketamine Infusion Clinic is a US-based ketamine clinic.

Major companies operating in the ketamine clinic market are Mindbloom Inc., Mindful Health Solutions, Neuro Wellness Spa, The Ketamine Clinic, Clarity Clinic, Revitalist Lifestyle and Wellness Ltd., Nushama, Innerwell, Klarisana Health, NY Ketamine Infusions, Axon Therapies Inc., Alleviant Health Centers, Lone Peak Psychiatry, MindPeace Clinics, NeuroRelief Ketamine & Infusion Therapy, Choose Your Horizon Inc., Innerbloom Ketamine Therapy, Viking Psychiatry, Norcal Ketamine Infusion Centers, Pacific KLN Infusions.

North America was the largest region in the ketamine clinic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ketamine clinic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ketamine clinic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the ketamine clinic market by increasing costs of imported pharmaceutical-grade ketamine, infusion equipment, monitoring devices, and clinical consumables used in treatment delivery. Clinics in North America and Europe are most affected due to dependence on imported medical supplies, while Asia-Pacific faces pricing pressures on pharmaceutical sourcing. These tariffs are contributing to higher treatment costs for patients. However, they are also encouraging domestic pharmaceutical production, local sourcing of clinical equipment, and greater standardization of ketamine therapy delivery models.

The ketamine clinic market research report is one of a series of new reports that provides ketamine clinic market statistics, including ketamine clinic industry global market size, regional shares, competitors with a ketamine clinic market share, detailed ketamine clinic market segments, market trends and opportunities, and any further data you may need to thrive in the ketamine clinic industry. This ketamine clinic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A ketamine clinic is a specialized medical facility designed to administer and monitor the use of ketamine under controlled, professional conditions. These clinics are typically staffed by licensed healthcare professionals and operate in accordance with regulatory and safety standards. The environment is structured to provide a secure and regulated setting that ensures proper dosage, patient monitoring, and overall risk management.

The primary therapies offered by ketamine clinics include online therapy and on-site therapy. Online therapy involves the use of digital platforms to provide mental health support through video calls, chat, or virtual consultations. These therapies are applied for conditions such as anxiety, depression, post-traumatic stress disorder (PTSD), and others. Administration modes include injectables, nasal sprays, and oral tablets. Ketamine clinic services are accessed by various end users, including individuals, hospitals and clinics, specialized ketamine centers, and research institutions.

The ketamine clinic market includes revenues earned by entities by administration services, pre- and post-session support, progress tracking, and vital sign monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.